Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Other Non-Current Liabilities (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Other Non-Current Liabilities data on record, last reported at $46000.0 in Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 85.8% year-over-year to $46000.0; the TTM value through Oct 2025 reached $46000.0, down 85.8%, while the annual FY2025 figure was $85000.0, 78.8% down from the prior year.
  • Other Non-Current Liabilities reached $46000.0 in Q4 2025 per CSBR's latest filing, down from $66000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $660000.0 in Q3 2022 and bottomed at $46000.0 in Q4 2025.
  • Average Other Non-Current Liabilities over 5 years is $344150.0, with a median of $343500.0 recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: surged 172.73% in 2022, then crashed 85.8% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $235000.0 in 2021, then surged by 165.53% to $624000.0 in 2022, then fell by 23.72% to $476000.0 in 2023, then plummeted by 31.93% to $324000.0 in 2024, then plummeted by 85.8% to $46000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $46000.0 in Q4 2025, $66000.0 in Q3 2025, and $85000.0 in Q2 2025.